Lexmark International (LXK) : 2 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Lexmark International (LXK). Zacks Investment Research suggests a Hold with a rank of 3.The median of all the 2 Wall Street Analysts endorse the stock as a Hold with a rating of 3.
Company shares have received an average consensus rating of Hold for the current week Lexmark International (NYSE:LXK): The stock opened at $35.40 on Thursday but the bulls could not build on the opening and the stock topped out at $35.47 for the day. The stock traded down to $35.11 during the day, due to lack of any buying support eventually closed down at $35.13 with a loss of -0.45% for the day. The stock had closed at $35.29 on the previous day. The total traded volume was 192,092 shares.
In a related news, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the director of Lexmark International Inc /Ky/, Hardis Stephen R, had purchased 797 shares in a transaction dated on January 4, 2016. The transaction was executed at $31.28 per share with total amount equaling $24,930.
Lexmark International Inc. (Lexmark) is a developer, manufacturer and supplier of printing, imaging, device management, managed print services (MPS), document workflow and business process and content management solutions. The Company operates in two segments: Imaging Solutions and Services (ISS) and Perceptive Software. It serves both the distributed printing and imaging, and content and process management markets with a focus on business customers. Lexmarks enterprise content and process management software platform supports traditional business content, as well as media and industry-specific content, such as medical image content and includes enterprise search, intelligent capture, document output management (DOM) and business process and case management. Lexmarks healthcare offering includes an industry content repository and vendor neutral archive (VNA) that integrates all patient unstructured information across the enterprise to enable access.